RxDoctor Payments Data

Freddie Marton

Neurology · Cedarhurst, NYNPI 1093733594

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.7% of the total across 173 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 12 manufacturers reported payments, led by Corium, LLC at 43.1% of the total.

$2,396in general payments, 2019–2025

Across 173 payments — averaging $13.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Corium, LLC$1K
  • Takeda Pharmaceuticals U.S.A., Inc.$572
  • Vertical Pharmaceuticals, LLC$294
  • Neos Therapeutics, LP$116
  • Supernus Pharmaceuticals, Inc.$83
  • AbbVie$78
  • plus $220 from 6 others

What the payments were for

  • Food & beverage$2,390100%
  • Education$60%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,396 in reported general payments places this provider in the 60th percentile of 1,623 neurology providers in New York.

See all neurology providers in New York →

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine13$674
Risperidone12$253
Olanzapine12$52

Paid to pharmacies, not to this prescriber.

Other neurology in Cedarhurst

See the full list for New York →

Where these figures come from

Is this you, or does something look wrong? →